Dendrite Names Nigel Whitehead Vice President of Global Accounts; Key Walsh/ST Executive Joins SFE Industry Leader Dendrite International.MORRISTOWN, NJ--(BUSINESS WIRE)--July 21, 1999-- Dendrite dendrite: see nervous system; synapse. International, Inc. (Nasdaq/NMS:DRTE DRTE Defence Research Telecommunications Establishment ) today announced the appointment of Nigel Whitehead, former Vice President of Business Development North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. at Walsh International (part of IMS (1) See IP Multimedia Subsystem. (2) (Information Management System) An early IBM hierarchical DBMS for IBM mainframes. IMS was widely implemented throughout the 1970s under MVS and continues to be used under z/OS. Health/Strategic Technologies), to the position of Dendrite Vice President, Global Accounts. Whitehead will be directly responsible for developing commercial strategies for key accounts. Dendrite announces the addition of Whitehead to its executive team as part of the Company's Global Reach Strategy and its commitment to strengthen and broaden Dendrite's positioning in multi-national markets. For the past 15 years, Whitehead has played a key role in expanding Walsh's services in Europe, the Middle East, Latin America Latin America, the Spanish-speaking, Portuguese-speaking, and French-speaking countries (except Canada) of North America, South America, Central America, and the West Indies. , and North America. "Dendrite is focused on providing value to our customers on a global basis," said Dendrite Senior Vice President of Worldwide Sales & Marketing, Mark Cieplik. "Few in this industry have had success in as many geographies and with as many pharmaceutical customers as Nigel, and we are thrilled to welcome him to the Dendrite executive team." "Dendrite has clearly established themselves as the leader in the Sales Force Effectiveness market space, on a global basis," said Whitehead. "I am pleased to be a part of an expanding executive team of such high quality and experience." A mechanical engineering graduate of Louborough University of Technology in Leicestershire, UK, Whitehead began his 15-year career with Walsh focusing on sales and management. His broad range of experience in the area of technology-enabled systems within the pharmaceutical industry is enhanced by his professional history of working with multi-national clients. ABOUT DENDRITE As a leading global provider of highly-specialized, integrated product and service offerings for the Pharmaceutical and Consumer Package Goods (CPG CPG central pattern generators. ) industries, Dendrite supports corporate strategies for a sustained competitive advantage. Thousands of sales representatives and their managers from over 150 companies and 57 countries rely on Dendrite for a uniquely tailored combination of tools, information and skills to help them prepare for tomorrow's challenges and improve their sales success. Focusing strongly on outcomes, Dendrite combines its modular software See modular programming. products with specifically tailored coaching and support services support services Psychology Non-health care-related ancillary services–eg, transportation, financial aid, support groups, homemaker services, respite services, and other services . With a global infrastructure as its foundation, Dendrite's commitment to unparalleled service has been the hallmark of the business and the basis of strong customer loyalty since the Company's inception in 1986. Headquartered in Morristown, New Jersey Morristown is a town in Morris County, New Jersey, United States. As of the United States 2000 Census, the town population was 18,544. Its estimated population in 2004 was 18,842. It is the county seat of Morris CountyGR6. , Dendrite employs over 1100 people around the world. For more information, visit the Company's Web site at http://www.drte.com. Note: Dendrite is a registered trademark of Dendrite International, Inc. This press release may contain statements that, if not verifiable historical fact, may be viewed as forward-looking statements that could predict future events or outcomes with respect to Dendrite and its business. The predictions embodied in these statements will involve risks and uncertainties and, accordingly, Dendrite's actual results may differ significantly from the results discussed or implied in such forward-looking statements. |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion